Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 2
2010 2
2011 3
2012 2
2014 1
2015 1
2021 2
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A. Le Pechoux C, et al. Lancet Oncol. 2022 Jan;23(1):104-114. doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 15. Lancet Oncol. 2022. PMID: 34919827 Clinical Trial.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group. Dunkle LM, et al. N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15. N Engl J Med. 2022. PMID: 34910859 Free PMC article. Clinical Trial.
Omalizumab: not only for asthma.
Ben-Shoshan M. Ben-Shoshan M. Recent Pat Inflamm Allergy Drug Discov. 2008 Nov;2(3):191-201. doi: 10.2174/187221308786241910. Recent Pat Inflamm Allergy Drug Discov. 2008. PMID: 19076009 Review.
Although omalizumab is generally well tolerated, reports on potential anaphylactic reactions as well as an association with Churg-Strauss syndrome necessitate close monitoring. The data reviewed are discussed with the aim of underlining unmet needs and making recommendatio …
Although omalizumab is generally well tolerated, reports on potential anaphylactic reactions as well as an association with Churg-Strauss …
Radiation countermeasure agents: an update.
Dumont F, Le Roux A, Bischoff P. Dumont F, et al. Expert Opin Ther Pat. 2010 Jan;20(1):73-101. doi: 10.1517/13543770903490429. Expert Opin Ther Pat. 2010. PMID: 20021286 Review.
Current update on eosinophilic lung diseases and anti-IL-5 treatment.
Samitas K, Rådinger M, Bossios A. Samitas K, et al. Recent Pat Antiinfect Drug Discov. 2011 Sep 1;6(3):189-205. doi: 10.2174/157489111796887855. Recent Pat Antiinfect Drug Discov. 2011. PMID: 21824072 Review.
Peripheral blood eosinophilia and eosinophilic lung inflammation are common in a variety of pulmonary conditions, including eosinophilic pneumonia and asthma, hypereosinophilic syndrome and Churg-Strauss syndrome. Therapy in most of these clinical entities consists of long …
Peripheral blood eosinophilia and eosinophilic lung inflammation are common in a variety of pulmonary conditions, including eosinophilic pne …
Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B.
Williams KB, Horst M, Young M, Pascua C, Puffenberger EG, Brigatti KW, Gonzaga-Jauregui C, Shuldiner AR, Gidding S, Strauss KA, Chowdhury D. Williams KB, et al. BMC Cardiovasc Disord. 2022 Mar 17;22(1):109. doi: 10.1186/s12872-022-02539-3. BMC Cardiovasc Disord. 2022. PMID: 35300601 Free PMC article.
METHODS: We employed advanced lipid profile testing, carotid intima media thickness (CIMT), pulse wave velocity (PWV), and peripheral artery tonometry (PAT) to assess atherosclerosis in a cohort of Amish ApoB(R3500Q) heterozygotes (n = 13), homozygotes (n = 3), and their u …
METHODS: We employed advanced lipid profile testing, carotid intima media thickness (CIMT), pulse wave velocity (PWV), and peripheral artery …
15 results